Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06537310 |
| Title | A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors. |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Hoffmann-La Roche |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | DNK | CAN | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UZ Leuven Gasthuisberg | RECRUITING | Leuven | 3000 | Belgium | Details | |
| Princess Margaret Cancer Center | RECRUITING | Toronto | Ontario | M5G 2M9 | Canada | Details |
| Rigshospitalet; Fase 1 Enhed - Onkologi | RECRUITING | København Ø | 2100 | Denmark | Details |